Xylem Inc is projected to report Q3 2026 revenue of $2.28 billion and adjusted earnings per share of $1.47, with shares currently trading at $108.74 against an average analyst price target of $142.63.
Investors are primarily focused on organic revenue growth as a barometer for municipal utility demand and the company's ability to navigate industrial sector headwinds.
While the company continues to realize synergies from the landmark Evoqua integration, recent analyst price-target reductions reflect caution regarding municipal budget cycles and project timing. Management’s commentary on the recent $1.46 billion acquisition of Cornell and Roper Pump will also be critical for assessing the firm's growth trajectory heading into 2027.